ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis

Links shared publicly online about this topic.

  • 742
    total visits

ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis

news-medical.net

Genentech, Inc., a member of the Roche Group today announced updated data from a Phase III study (ROSE) that showed rheumatoid arthritis (RA) patients receiving ACTEMRA (tocilizumab) experienced a rapid, measured response as early as one week after beginning ACTEMRA, and improvement in disease activity within four weeks.

View full resource at news-medical.net

Tags: Arthritis, Rheumatoid Arthritis, Rheumatoid Arthritis Medication, Disease and Condition, Actemra, Genentech, disease

  • Share

Most Recently Shared on November 8, 2010 at 12:41 pm By:

RA_Wisdom OrganizedWisdom RA

ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis: Genentech, Inc., a member of the Roche Gr... http://bit.ly/dbhtqB

1 year ago...

What are the symptoms and signs of rheumatoid arthritis? | BJC Connected Care

bjchealth.com.au — “Rheumatoid arthritis commonly affects the small joints of the hands and feet in a symmetrical pattern; however, the large joints such as elbows, shoulders,View full resource at bjchealth.com.au

  • View Related
  • Share

Most Recently Shared on August 24, 2011 at 6:20 pm By:

ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis

twurl.nl — “Genentech, Inc., a member of the Roche Group today announced updated data from a Phase III study (ROSE) that showed rheumatoid arthritis (RA) patients receiving ACTEMRA (tocilizumab) experienced a rapid, measured response as early as one week after beginning ACTEMRA, and improvement in disease activity within four weeks.View full resource at twurl.nl

  • View Related
  • Share

Most Recently Shared on November 8, 2010 at 11:36 am By:

Stroke_News News-Medical.Net Health News

Stroke News: ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis: Genentech, Inc., a member ... http://twurl.nl/6p6ovr

1 year ago...

ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis

news-medical.net — “Genentech, Inc., a member of the Roche Group today announced updated data from a Phase III study (ROSE) that showed rheumatoid arthritis (RA) patients receiving ACTEMRA (tocilizumab) experienced a rapid, measured response as early as one week after beginning ACTEMRA, and improvement in disease activity within four weeks.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on November 8, 2010 at 7:28 am By:

NewsMedical News-Medical.Net Health News

ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis: Genentech, Inc., a member of the Roche Gr... http://bit.ly/a270wI

1 year ago...

Healthcare Professionals - Rheumatoid Arthritis

remicade.com — “Learn about rheumatoid arthritis and how REMICADE" (infliximab) is indicated for inhibiting joint damage in patients with moderate to severe rheumatoid arthritis.View full resource at remicade.com

  • View Related
  • Share

Most Recently Shared on April 25, 2010 at 5:42 pm By:

SusanS_Health Susan Scroggins Health Advocate and Active Health Library

Understanding the pathophysiology of rheumatoid arthritis. Info for health professionals from Remicade. http://bit.ly/9F0A90

2 years ago...

Study: Actemra better than placebo in late-stage trial - Related Stories - AAP SmartBrief

smartbrief.com — “More patients who took Roche Holding's Actemra had reduced signs and symptoms of systemic onset juvenile idiopathic arthritis than those given placebo after 12 weeks of treatment in a Phase III trial. The finding adds to evidence of Actemra's efficacy for arthritis, including another late-stage studView full resource at smartbrief.com

  • View Related
  • Share

Most Recently Shared on November 20, 2009 at 11:14 pm By:

songMD Clara Song Physician, Doctor, and Pediatrician

Study: Actemra better than placebo in late-stage trial http://sbne.ws/r/3jBZ

2 years ago...

Advertisement